Recent News

• 07.22.2025 - Kiora Pharmaceuticals Granted U.S. Patent Expanding Protection for KIO-104 in the Treatment of Ocular Disease
• 05.05.2025 - Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy

Recent Filings

• 06.04.2025 - 8-K Current report
• 06.03.2025 - EX-99.1 EX-99.1
• 06.03.2025 - 8-K Current report
• 05.09.2025 - EX-99.1 EX-99.1
• 05.09.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.09.2025 - 8-K Current report
• 04.30.2025 - DEF 14A Other definitive proxy statements
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities